Does a combined intravenous and subcutaneous insulin strategy improve outcomes after cardiothoracic surgery?

Affiliations

¹ Division of Endocrinology, University of North Carolina-Chapel Hill, 8027 Burnett-Womack CB 7172, 160 Dental Circle, Chapel Hill, NC 27599-7172, USA. sbraithw@med.unc.edu

Comment

Susan Shapiro Braithwaite. Nat Clin Pract Endocrinol Metab. 2007 Oct.

. 2007 Oct;3(10):680-1.

doi: 10.1038/ncpendmet0589. Epub 2007 Jul 31.

¹ Division of Endocrinology, University of North Carolina-Chapel Hill, 8027 Burnett-Womack CB 7172, 160 Dental Circle, Chapel Hill, NC 27599-7172, USA. sbraithw@med.unc.edu

No abstract available

Comment on

Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.
Schmeltz LR, DeSantis AJ, Thiyagarajan V, Schmidt K, O'Shea-Mahler E, Johnson D, Henske J, McCarthy PM, Gleason TG, McGee EC, Molitch ME. Schmeltz LR, et al. Diabetes Care. 2007 Apr;30(4):823-8. doi: 10.2337/dc06-2184. Epub 2007 Jan 17. Diabetes Care. 2007. PMID: 17229943 Clinical Trial.